Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Finasteride may help treat hair loss in postmenopausal women.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

French maritime pine bark extract significantly increased hair density in menopausal women.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Menopause-related skin changes may increase fungal infections and inflammation.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Topical DHEA safely increases skin oil production.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.